First-line endocrine therapy for postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and meta-analysis

BACKGROUND: In establishing the 2018 Breast Cancer Practice Guidelines of the Japan Breast Cancer Society, we explored the optimal first-line endocrine therapy for advanced postmenopausal hormone receptor-positive breast cancer. METHODS: We performed a systematic review of relevant reports from rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimoi, Tatsunori, Sagara, Yasuaki, Hara, Fumikata, Toyama, Tatsuya, Iwata, Hiroji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2020
Materias:
Special Feature
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196086/
https://www.ncbi.nlm.nih.gov/pubmed/32043218
http://dx.doi.org/10.1007/s12282-020-01054-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196086/
https://www.ncbi.nlm.nih.gov/pubmed/32043218
http://dx.doi.org/10.1007/s12282-020-01054-7

Ejemplares similares